semaglutide and eyesight GLP-1 medications eye problem risks Semaglutide linked to sight-threatening eye

In the current pandemic, about 40% of COVID-19 patients demonstrated neurological symptoms, lingering neuro-inflammation, where neuronal damage in PASC patients has emerged as a novel syndrome, the Neuro-COVID 169,171

G., Poppitt, S

doi: 10.1186/s12933-019-0934-x

The significant improvement in the patient's health is consistent with the theory that supplementing GLP-1 therapy with GIP pharmacology improves glucose control through the double action on the pancreatic cells, which would lead to the enhancement of insulin secretion

In the kidney, dual GLP-1R/GIPR stimulation attenuates MCP-1, IL-6, and tumor necrosis factor (TNF)- expression and down-regulates SGLT2 messenger ribonucleic acid (mRNA), potentially reinforcing natriuresis and glycosuria when GLP-1RA are combined with SGLT2 inhibitors [26]